Evidence map›Paper›PMID 41435222›Full record

ArticleNeurology(R) neuroimmunology & neuroinflammation2026

Sex Bias in IL-10 Production by Type I Regulatory T Cells Regulated by PI3K/mTOR Signaling.

Aymeline Debonlier, Saniya Kari, Florence Bucciarelli, Thibault Angles, Amelia Perez-Pestel, Chanaëlle Fébrissy, Sophie Laffont, Roland Liblau, Françoise Lenfant, Shannon Elizabeth Dunn and 2 more

Abstract read
In one paragraph

Article in Neurology(R) neuroimmunology & neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Aymeline DebonlierToulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.ORCID 0009-0007-0820-8024
Saniya KariToulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.ORCID 0009-0002-5392-0428
Florence BucciarelliToulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.ORCID 0000-0003-2368-9165
Thibault AnglesToulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.
Amelia Perez-PestelToulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.
Chanaëlle FébrissyUniversité de Toulouse, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), INSERM U1297, France.ORCID 0000-0002-3819-4248
Sophie LaffontToulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.ORCID 0000-0003-2319-0217
Roland LiblauToulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.ORCID 0000-0001-5477-5475
Françoise LenfantUniversité de Toulouse, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), INSERM U1297, France.
Shannon Elizabeth DunnSunnybrook Research Institute, University of Toronto, Ontario, Canada; and.ORCID 0000-0002-6878-0563
Julie Guillermet-GuibertCentre de recherche en cancérologie (CRCT)-Oncopole, Inserm UMR1037, CNRS UMR5071, Université de Toulouse, France.ORCID 0000-0003-3173-4907
Anne L AstierToulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.ORCID 0000-0002-0144-3431

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesMultiple sclerosis (MS) is more prevalent in women, with a female-to-male ratio of 3:1. The molecular mechanisms driving this sex difference are still mostly unknown. MS results from immune dysfunction, with an imbalance in effector and regulatory T cells. Among the latter, Type I regulatory T cells (Tr1) are dysfunctional in people with MS (pwMS), secreting less IL-10, a potent anti-inflammatory cytokine, than in healthy donors. Our objectives were to explore the effect of biological sex on Tr1 cell differentiation in healthy donors and pwMS.

methodsCD4

resultsWe found that healthy female Tr1 cells produce less IL-10 than male cells (16 women and 16 men, 18-45 years old, DISCUSSION: We demonstrate that sex influences IL-10 production by Tr1 cells via the PI3K pathway, potentially contributing to the greater susceptibility of women to MS. Furthermore, our data suggest that targeting PI3Kδ may represent a novel therapeutic strategy to boost IL-10 production in female pwMS.

Indexed as

Interleukin-10Multiple SclerosisPhosphatidylinositol 3-KinasesT-Lymphocytes, RegulatoryTOR Serine-Threonine KinasesAdultFemaleHumansMaleMiddle AgedSignal TransductionYoung AdultIL10 protein, humanInterleukin-10MTOR protein, humanPhosphatidylinositol 3-KinasesTOR Serine-Threonine Kinases

Identifiers

PMID41435222
PMCPMC12735307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.